The global interventional cardiology & peripheral vascular devices market size is estimated to be USD 21.96 billion in 2021 and is expected to witness a CAGR of 7.81% during the forecast period. Rising geriatric population along with growth in cases of chronic diseases is a key driver for the growth of the global interventional cardiology & peripheral vascular devices market. Additionally, technological developments in the market and refining healthcare set-up in developing countries are some of the other drivers propelling the market growth. Nevertheless, high cost of cardiology treatment and stringent regulatory framework for manufacturing new devices are expected to restrain the global market growth.
Based on specialty type, the market is categorized into angioplasty catheters, angioplasty balloons, endovascular aneurysm repair stent grafts, angioplasty stents, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. In 2021, the angioplasty catheters segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to increase in prevalence of coronary artery diseases (CAD), along with the rising awareness about the benefits of the initial diagnosis of CADs worldwide. The angioplasty stents segment is anticipated to grow at a profitable CAGR during the forecast period, due the technological developments and new product launches in developed regions.
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in ageing population, changes in lifestyle of the people, the frequency of chronic diseases, and accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the expenditure on developing their healthcare infrastructure. Thus, the rise in public and private investments for development of the healthcare infrastructure in this region will promote the growth rate of adopting the interventional cardiology and peripheral vascular devices in developing countries. Competitor Insights Some of the key players in the interventional cardiology & peripheral vascular devices market are Abbott Laboratories (U.S.); B. Braun Melsungen AG (Germany); Boston Scientific Corporation (U.S.); C. R. Bard, Inc. (U.S.); Cardinal Health, Inc. (U.S.); Cook Medical, Inc. (U.S.); Medtronic plc (Ireland); St. Jude Medical, Inc. (U.S.); Terumo Corporation (Japan); and The Spectranetics Corporation (U.S.). The leading players operating in the interventional cardiology & peripheral vascular devices industry are adopting various strategies including R&D investments, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The interventional cardiology & peripheral vascular devices market report is categorized into the following segments and subsegments:
By Specialty Type
Based on specialty type, the market is categorized into angioplasty catheters, angioplasty balloons, endovascular aneurysm repair stent grafts, angioplasty stents, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. In 2021, the angioplasty catheters segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to increase in prevalence of coronary artery diseases (CAD), along with the rising awareness about the benefits of the initial diagnosis of CADs worldwide. The angioplasty stents segment is anticipated to grow at a profitable CAGR during the forecast period, due the technological developments and new product launches in developed regions.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in ageing population, changes in lifestyle of the people, the frequency of chronic diseases, and accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the expenditure on developing their healthcare infrastructure. Thus, the rise in public and private investments for development of the healthcare infrastructure in this region will promote the growth rate of adopting the interventional cardiology and peripheral vascular devices in developing countries. Competitor Insights Some of the key players in the interventional cardiology & peripheral vascular devices market are Abbott Laboratories (U.S.); B. Braun Melsungen AG (Germany); Boston Scientific Corporation (U.S.); C. R. Bard, Inc. (U.S.); Cardinal Health, Inc. (U.S.); Cook Medical, Inc. (U.S.); Medtronic plc (Ireland); St. Jude Medical, Inc. (U.S.); Terumo Corporation (Japan); and The Spectranetics Corporation (U.S.). The leading players operating in the interventional cardiology & peripheral vascular devices industry are adopting various strategies including R&D investments, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The interventional cardiology & peripheral vascular devices market report is categorized into the following segments and subsegments:
Interventional Cardiology & Peripheral Vascular Devices Market, By Product (Revenue, USD Billion, 2021 - 2029)
Angioplasty Catheters
- Angiography Catheters
- Guiding Catheters
Angioplasty Balloons
- Old/Normal balloons
- Cutting and scoring balloons
- Drug eluting balloons
Endovascular Aneurysm Repair Stent Grafts
- Abdominal aortic aneurysm
- Thoracic aortic aneurysm
Angioplasty Stents
- Coronary stents
- Bare-metal stents
- Drug-eluting stents (DES)
Bioabsorbable stents
- Peripheral stents
Inferior Vena Cava (IVC) Filters
- Permanent filters
- Retrievable filters
Plaque Modification Devices
- Thrombectomy devices
- Atherectomy devices
Hemodynamic Flow Alteration Devices
- Embolic protection devices
- Chronic total occlusion devices
Accessories
- Vascular closure devices
- Introducer sheaths
- Guidewires
- Balloon inflation devices
Interventional Cardiology & Peripheral Vascular Devices Market, By Region (Revenue, USD Billion, 2021 - 2029)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Table of Contents
1. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Interventional Cardiology & Peripheral Vascular Devices Market
7. Market Analysis by Product
8. Regional Market Analysis
9. North America Interventional Cardiology & Peripheral Vascular Devices Market
10. Europe Interventional Cardiology & Peripheral Vascular Devices Market
11. Asia Pacific Interventional Cardiology & Peripheral Vascular Devices Market
12. Latin America Interventional Cardiology & Peripheral Vascular Devices Market
13. MEA Interventional Cardiology & Peripheral Vascular Devices Market
14. Competitor Analysis
15. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories (U.S.)
- B. Braun Melsungen AG (Germany)
- Boston Scientific Corporation (U.S.)
- C. R. Bard Inc. (U.S.)
- Cardinal Health Inc. (U.S.)
- Cook Medical Inc. (U.S.)
- Medtronic plc (Ireland)
- St. Jude Medical Inc. (U.S.)
- Terumo Corporation (Japan)
- The Spectranetics Corporation (U.S.)
